:


Gates WJ et al: Worldwide patterns of infertility: Is Africa different? Lancet 2:596, 1985

Centers for Disease Control and Prevention: Policy guidelines for the prevention and management of pelvic inflammatory disease. Morb Mort Week Rep 40(RR-5): 1, 1992

Centers for Disease Control and Prevention: 1993 Sexually transmitted disease treatment guidelines. Morb Mort Week Rep 42(RR14):T-102, 1993

Dodson MG: Antibiotic regimens for treating acute pelvic inflammatory disease. An evaluation. J Reprod Med 39:285, 1994

Eschenbach DA et al: Polymicrobial etiology of acute pelvic inflammatory disease. N Engl J Med 293:166, 1975

Falk V et al: Genital tuberculosis in women. Am J Obstet Gynecol 138:974, 1980

Ferris DG et al: Women's use of over-the-counter antifungal medications for gynecologic symptoms. J Fam Pract 42:595, 1996

Germaine A et al: Reproductive Tract Infections: Global Impact and Priorities for Women's Reproductive Health. New York, Plenum, 1992

Hasselquist MB, Hillier S: Susceptibility of upper-genital tract isolates from women with pelvic inflammatory disease to ampicillin, cefpodoxime, metronidazole, and doxycycline. Sex Transm Dis 18:146, 1991

Hemsell DL et al: Comparison of three regimens recommended by the Centers for Disease Control and Prevention for the treatment of women hospitalized with acute pelvic inflammatory disease. Clin Infect Dis 19:729, 1994

Hillier SL et al: Role of bacterial vaginosis-associated microorganisms in endometritis. Am J Obstet Gynecol 175:435, 1996

Hillis SD et al: Delayed care of pelvic inflammatory disease as a risk factor for impaired fertility. Am J Obstet Gynecol 168:1503, 1993

Kamenga MC et al: The impact of human immunodeficiency virus infection on pelvic inflammatory disease: A case-control study in Abidjan, Ivory Coast. Am J Obstet Gynecol 172:919, 1995

Kimani J et al: Risk factors for Chlamydia trachomatis pelvic inflammatory disease among sex workers in Nairobi, Kenya. J Infect Dis 173:1437, 1996

Kiviat N et al: Endometrial histopathology in patients with cultureproven upper genital tract infection and laparoscopically diagnosed acute salpingitis. Am J Surg Pathol 14:167, 1990

Lenders DV et al: Combination antimicrobial therapy in the treatment of acute pelvic inflammatory disease. Am J Obstet Gynecol 164:849, 1991

Peipert JF et al: Laboratory evaluation of acute upper genital tract infection. Obstet Gynecol 87(pt 1):730, 1996

Plummer FA et al: Postpartum upper genital tract infections in Nairobi, Kenya: Epidemiology, etiology, and risk factors. J Infect Dis 156:92, 1987

Reed SD et al: Antibiotic treatment of tuboovarian abscess: Comparison of broad-spectrum beta-lactam agents versus clindamycincontaining regimens. Am J Obstet Gynecol 164:1556, 1991

Scholes D et al: Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 334:1362, 1996

St John RK, Brown ST (eds): International symposium on pelvic inflammatory disease. Am J Obstet Gynecol 138:845, 1980

Svensson L et al: Infertility after acute salpingitis.with special reference to Chlamydia trachomatis-associated infections. Fertil Steril 40:322, 1983

Walker CK et al: Pelvic inflammatory disease: Meta-analysis of antimicrobial regimen efficacy. J Infect Dis 168:969, 1993

Washington AE, Katz P: Cost of and payment source for pelvic inflammatory disease: Trends and projections, 1983 through 2000. JAMA 266:2565, 1991

Wasserheit JN et al: Microbial causes of proven pelvic inflammatory disease and efficacy of clindamycin with tobramycin. Ann Intern Med 104:187, 1986

Wolner-Hanssen P: Silent pelvic inflammatory disease: Is it overstated? Obstet Gynecol 86:321, 1995

: